Back to Screener

Financial Services

Alpha Healthcare Acquisition Corp. III(ALPAW)

Live Price

Offline

$0.26

-7.14% today

1Y Change

Window

No data

Market Cap
Revenue Growth
0.0%
EPS Growth
-7615.7%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Alpha Healthcare Acquisition Corp. III (ALPAW) is a Financial Services stock. The stock last traded around $0.26. Baseline metrics include revenue growth of 0.0%, EPS growth of -7615.7%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -7615.7%, free cash flow +23.8% with operating margin -371.6% and ROIC 130.3%. Valuation already assumes a fairly strong business story at price/sales 101.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ALPAW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

0.0% vs +3.4% peer median

Operating Margin

Below sector median

-371.6% vs +4.7% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2023 was reported on Mar 31, 2023, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at 0.0% and EPS is at -7615.7%, with operating margin around -371.6%.

Benchmark Edge

ALPAW vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

ALPAW

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

ALPAW Max Drawdown

Trailing 1Y

SPY Max Drawdown

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ALPAW and SPY.

Calendar-year return history is still loading or unavailable.
AL

Company Overview

Alpha Healthcare Acquisition Corp. III

Last Updated
May 7, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
EV/EBITDA
Price/Sales
101.3
Price/Book

Growth

Revenue
0.0%
EPS
-7615.7%
Free Cash Flow
+23.8%

Profitability

Gross Margin
57.2%
Operating Margin
-371.6%
Net Margin
-361.0%
ROE
158.9%
ROIC
130.3%

Balance Sheet

Debt/Equity
Current Ratio
0.25

Earnings Reports

📅 Last reportedMar 31, 2023
PeriodB/MEPSEPS ΔRevenueRev Δ
Mar 31, 23
0.15
Est
Est
Dec 31, 22
0.02
Est
Est

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.